Share chart Novan, Inc.
Extended chart
Simple chart
About Novan, Inc.
Novan, Inc., биотехнологическая компания, находящаяся на стадии клинических разработок, предлагает препараты на основе оксида азота для лечения дерматологических и онковирусных заболеваний. more detailsMain settings
IPO date
2016-09-21
ISIN
US66988N2053
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 1.3 | 9 |
| P/BV | 6.65 | 1 |
| P/E | 14.9 | 8 |
Efficiency
| Title | Value | Grade |
| ROA | -24.56 | 0 |
| ROE | -170.66 | 0 |
| ROIC | -217.13 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -0.1154 | 10 |
| Debt/Ratio | 0.0432 | 10 |
| Debt/Equity | 18.63 | 0 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 178 | 10 |
| Yield Ebitda, % | 31.79 | 5 |
| Yield EPS, % | -83.68 | 0 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 0.0347 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 0.0347 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Month | 0.0347 $ | 0.0347 $ | 0.0347 $ | 0 % | 0 % | 0 % |
| Three month | 0.0347 $ | 0.0347 $ | 0.0347 $ | 0 % | 0 % | 0 % |
| Half a year | 0.0347 $ | 0.0347 $ | 0.0347 $ | 0 % | 0 % | 0 % |
| Year | 0.0347 $ | 0.0347 $ | 0.0347 $ | 0 % | 0 % | 0 % |
| 3 years | 2.5 $ | 0.02 $ | 3.03 $ | -98.61 % | 0 % | 0 % |
| 5 years | 5.05 $ | 0.02 $ | 140 $ | -99.31 % | 0 % | 0 % |
| 10 years | 0 $ | 0.02 $ | 282.9 $ | 0 % | 0 % | 0 % |
| Year to date | 0.0347 $ | 0.0347 $ | 0.0347 $ | 0 % | 0 % | 0 % |
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Xtrackers MSCI All World ex US High Dividend Yield Equity ETF | 4.43 | -0.9336 | 0.20 |
| Credit Suisse FI Enhanced Europe 50 ETN | 2.14 | 49.45 | 2.00 |
| FCF International Quality ETF | 2.12775 | -1.15 | 0.59 |
| Franklin LibertyQ International Equity Hedged ETF | 2.01 | -12.88 | 0.40 |
| Franklin FTSE Europe Hedged ETF | 1.98 | 0.5585 | 0.09 |
| WisdomTree International ESG Fund | 1.95 | 26.8 | 0.30 |
| SoFi Weekly Dividend ETF | 1.54 | 6.64 | 0.49 |
| JPMorgan ActiveBuilders International Equity ETF | 1.44 | 0 | 0.25 |
| FlexShares International Quality Dividend Defensive Index Fund | 1.34014 | -7.89 | 0.47 |
| First Trust Developed International Equity Select ETF | 1.15 | 22.94 | 0.65 |
| Principal International Multi-Factor ETF | 0.93 | 30.17 | 0.25 |
| Principal International Adaptive Multi-Factor ETF | 0.64 | 0 | 0.24 |
| DeltaShares S&P International Managed Risk ETF | 0.58 | 22.5 | 0.50 |
| IQ 500 International ETF | 0.57596 | -4.21 | 0.25 |
| VictoryShares Developed Enhanced Volatility Wtd ETF | 0.29278 | 0.8332 | 0.51 |
| 1.54 | 8.86 | 0.48 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Ms. Paula Brown Stafford M.P.H. | Pres, CEO & Chairwoman | 623.23k | 1965 (60 years) |
| Mr. John M. Gay CPA | CFO & Corp. Sec. | 386.89k | 1976 (49 years) |
| Dr. Carri Geer Ph.D. | Sr. VP & CTO | N/A | |
| Dr. Tomoko Maeda-Chubachi M.B.A., M.D., Ph.D. | Chief Medical Officer | N/A | |
| Mr. John A. Donofrio Jr. | Exec. VP, COO & Pres of EPI Health | 602.51k | 1967 (58 years) |
| Mr. Brian M. Johnson | Chief Commercial Officer | 1966 (59 years) | |
| Mr. Andrew J. Novak | VP of Accounting & Bus. Operations and Chief Accounting Officer | ||
| Mr. Cole Ikkala | Director of Investor Relations, Communications & Bus. Devel. | ||
| Mr. Stanley Hollenbach BS, J.D. | Sr. VP of R&D |
About company
Address: United States, Morrisville, 4105 Hopson Road - Open in google maps, Open in yandex maps
Website: http://www.novan.com
Website: http://www.novan.com
